Cardiff Oncology Stock Fundamentals
XE7C Stock | EUR 5.33 0.07 1.40% |
Cardiff Oncology fundamentals help investors to digest information that contributes to Cardiff Oncology's financial success or failures. It also enables traders to predict the movement of Cardiff Stock. The fundamental analysis module provides a way to measure Cardiff Oncology's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cardiff Oncology stock.
Cardiff |
Cardiff Book Value Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cardiff Oncology's direct or indirect competition against its Book Value Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cardiff Oncology could also be used in its relative valuation, which is a method of valuing Cardiff Oncology by comparing valuation metrics of similar companies.Cardiff Oncology is currently under evaluation in book value per share category among related companies.
Cardiff Fundamentals
Return On Equity | -0.32 | |||
Return On Asset | -0.19 | |||
Operating Margin | (102.39) % | |||
Current Valuation | (45.06 M) | |||
Shares Outstanding | 44.68 M | |||
Shares Owned By Insiders | 7.30 % | |||
Shares Owned By Institutions | 23.02 % | |||
Price To Book | 0.57 X | |||
Price To Sales | 147.11 X | |||
Revenue | 359 K | |||
Gross Profit | (17.02 M) | |||
EBITDA | (27.84 M) | |||
Net Income | (28.29 M) | |||
Cash And Equivalents | 140.05 M | |||
Cash Per Share | 3.54 X | |||
Total Debt | 408 K | |||
Debt To Equity | 0 % | |||
Current Ratio | 31.20 X | |||
Book Value Per Share | 2.61 X | |||
Cash Flow From Operations | (23.04 M) | |||
Earnings Per Share | (0.81) X | |||
Target Price | 25.33 | |||
Number Of Employees | 22 | |||
Beta | 1.66 | |||
Market Capitalization | 77.48 M | |||
Total Asset | 149.54 M | |||
Net Asset | 149.54 M |
About Cardiff Oncology Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cardiff Oncology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cardiff Oncology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cardiff Oncology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops drugs for the treatment of cancer. Cardiff Oncology, Inc. was incorporated in 1999 and is headquartered in San Diego, California. CARDIFF ONCOLOG operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 11 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Cardiff Oncology in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Cardiff Oncology's short interest history, or implied volatility extrapolated from Cardiff Oncology options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.CLSK | CleanSpark | |
V | Visa Class A | |
CDLX | Cardlytics |
Check out Cardiff Oncology Piotroski F Score and Cardiff Oncology Altman Z Score analysis. For more detail on how to invest in Cardiff Stock please use our How to Invest in Cardiff Oncology guide.Note that the Cardiff Oncology information on this page should be used as a complementary analysis to other Cardiff Oncology's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Complementary Tools for Cardiff Stock analysis
When running Cardiff Oncology's price analysis, check to measure Cardiff Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardiff Oncology is operating at the current time. Most of Cardiff Oncology's value examination focuses on studying past and present price action to predict the probability of Cardiff Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardiff Oncology's price. Additionally, you may evaluate how the addition of Cardiff Oncology to your portfolios can decrease your overall portfolio volatility.
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Stocks Directory Find actively traded stocks across global markets | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |